GOLD T-TECH, INC.

Medtech

Real-time electrogram morphology recurrence mapping software for identifying atrial fibrillation sources during ablation procedures

Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Mapping electrogram morphology recurrence for atrial fibrillation ablation$225,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2208BAY GENOMICS, LLC——
2209COGNIFISENSE, INC.——
2210VECTOR SURGICAL, LLC——
2211GOLD T-TECH, INC.——
2212Cardiac Dynamics LLC——
2213BELAY DIAGNOSTICS, LLC——
2214VANISH THERAPEUTICS INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Method For Preventing Thrombus Formationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.